Search

everythinglearnresearchcommunity

for

Search:↓

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Topical minoxidil improved hair loss in a patient when used consistently.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Castration significantly reduces prostate size and BPH symptoms.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Male pattern baldness may be linked to prostate cancer risk.

Provenge extends prostate cancer survival by about 4 months.

Dutasteride is approved to help manage prostate enlargement.

Urologists should screen for mental health issues before and during finasteride treatment.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

The cause of post-finasteride syndrome is unclear and needs more research.